Drug efficacy

All-in-one solution for the development of 3D liver models

28 May 2021

The HepGo Assay-ready 3D Liver Spheroid Kit leverages Corning Life Science’s 3D cell culture technology in liver biology and ADME/Tox. Corning has developed an all-in-one solution for the development of 3D liver models that has been designed to better recapitulate in vivo behaviour. The kit is said to deliver a more physiologically relevant model over […]

How to enhance the predictability of preclinical development: webinar

27 May 2021

Effective preclinical assessment of drug safety and efficacy is essential to help reduce the risk of drug-induced toxicity and late-stage drug attrition. Current preclinical tests for safety depend on in vivo testing in higher-order species to achieve translational accuracy; however, animal models are expensive and do not adequately recapitulate human physiology due to species differences. […]

Novadiscovery collaborate with Takeda for new clinical simulation

26 March 2021

Novadiscovery (NOVA), a health tech company offering JINKO, a clinical trial simulation platform to predict drug efficacy and optimise clinical trial development, has announced its new collaboration with Takeda Pharmaceutical. This is aimed at incorporating clinical simulation technology on virtual patients into Takeda France’s access strategy and building on an existing relationship between the companies […]